SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales surged to Rs. 14327.50 millions, up 28.28% for the June 2025 quarter as against Rs. 11169.30 millions during the corresponding quarter previous year.The Net Profit of the company vaulted to 448.78% to Rs. 1579.40  millions from Rs. 287.80 millions in the previous quarter.OP of the company witnessed a marginal growth to 3489.00 millions from 1706.90 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 14327.50 11169.30 28.28 14327.50 11169.30 28.28 52169.80 48123.90 8.41
Other Income 215.20 93.00 131.40 215.20 93.00 131.40 1004.70 474.20 111.87
PBIDT 3489.00 1706.90 104.41 3489.00 1706.90 104.41 10448.00 7973.00 31.04
Interest 438.90 408.90 7.34 438.90 408.90 7.34 1822.00 1508.20 20.81
PBDT 3050.10 1298.00 134.98 3050.10 1298.00 134.98 8626.00 6464.80 33.43
Depreciation 935.70 910.00 2.82 935.70 910.00 2.82 3587.90 3450.10 3.99
PBT 2114.40 388.00 444.95 2114.40 388.00 444.95 5038.10 3014.70 67.12
TAX 535.00 100.20 433.93 535.00 100.20 433.93 1234.20 777.70 58.70
Deferred Tax -61.60 -72.40 -14.92 -61.60 -72.40 -14.92 -304.20 -101.70 199.12
PAT 1579.40 287.80 448.78 1579.40 287.80 448.78 3803.90 2237.00 70.04
Equity 1079.60 1078.30 0.12 1079.60 1078.30 0.12 1078.50 1077.90 0.06
PBIDTM(%) 24.35 15.28 59.35 24.35 15.28 59.35 20.03 16.57 20.88

Laurus Labs Share Price

1135.00 5.40 (0.48%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×